Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 1
2004 5
2006 4
2007 4
2008 7
2009 4
2010 12
2011 13
2012 10
2013 10
2014 11
2015 13
2016 18
2017 12
2018 11
2019 13
2020 13
2021 18
2022 27
2023 22
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Results by year

Filters applied: . Clear all
Page 1
Probes for the heterogeneity of muscimol binding sites in rat brain.
Müller V, Ernst M, Baykuchkarova A, Koniuszewski F, Bampali K, Seidel T, Scholze P. Müller V, et al. Front Pharmacol. 2024 Mar 14;15:1368527. doi: 10.3389/fphar.2024.1368527. eCollection 2024. Front Pharmacol. 2024. PMID: 38549678 Free PMC article.
Brain expression profiles of two SCN1A antisense RNAs in children and adolescents with epilepsy.
Schneider MF, Vogt M, Scheuermann J, Müller V, Fischer-Hentrich AHL, Kremer T, Lugert S, Metzger F, Kudernatsch M, Kluger G, Hartlieb T, Noachtar S, Vollmar C, Kunz M, Tonn JC, Coras R, Blümcke I, Pace C, Heinen F, Klein C, Potschka H, Borggraefe I. Schneider MF, et al. Among authors: muller v. Transl Neurosci. 2024 Jan 23;15(1):20220330. doi: 10.1515/tnsci-2022-0330. eCollection 2024 Jan 1. Transl Neurosci. 2024. PMID: 38283997 Free PMC article.
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
Drilon A, Camidge DR, Lin JJ, Kim SW, Solomon BJ, Dziadziuszko R, Besse B, Goto K, de Langen AJ, Wolf J, Lee KH, Popat S, Springfeld C, Nagasaka M, Felip E, Yang N, Velcheti V, Lu S, Kao S, Dooms C, Krebs MG, Yao W, Beg MS, Hu X, Moro-Sibilot D, Cheema P, Stopatschinskaja S, Mehta M, Trone D, Graber A, Sims G, Yuan Y, Cho BC; TRIDENT-1 Investigators. Drilon A, et al. N Engl J Med. 2024 Jan 11;390(2):118-131. doi: 10.1056/NEJMoa2302299. N Engl J Med. 2024. PMID: 38197815 Clinical Trial.
The Impact of Switching to a Second Antifibrotic in Patients With Idiopathic Pulmonary Fibrosis: A Retrospective Multicentre Study From the EMPIRE Registry.
Gregor J, Adir Y, Šterclová M, Mogulkoc N, Kramer MR, Doubková M, Plačková M, Müller V, Studnicka M, Žurková M, Lacina L, Lewandowska K, Bartoš V, Ovesná P, Májek O, Koziar Vašáková M. Gregor J, et al. Among authors: muller v. Arch Bronconeumol. 2024 Feb;60(2):80-87. doi: 10.1016/j.arbres.2023.12.002. Epub 2023 Dec 18. Arch Bronconeumol. 2024. PMID: 38160169 English, Spanish.
Waning of SARS-CoV-2 Vaccine Effectiveness in COPD Patients: Lessons from the Delta Variant.
Polivka L, Valyi-Nagy I, Szekanecz Z, Bogos K, Vago H, Kamondi A, Fekete F, Szlavik J, Surjan G, Surjan O, Nagy P, Schaff Z, Kiss Z, Müller C, Kasler M, Müller V. Polivka L, et al. Among authors: muller v. Vaccines (Basel). 2023 Nov 29;11(12):1786. doi: 10.3390/vaccines11121786. Vaccines (Basel). 2023. PMID: 38140190 Free PMC article.
212 results